Despite lots of headlines, an underappreciated storyline this year was the undercurrent surrounding the validity of medical tests: —The Milwaukee Journal Sentinel published a long Watchdog Report focused primarily on quality issues with waived lab tests, which don’t require FDA approval. —The headline of a shorter version in the Wall Street Journal asked whether lab … Continue reading “Medical Test Validity Will Be Debated In 2016: 5 Storylines To Watch”
Author: Laura Strong
Laura E. Strong, Ph.D. has more than 15 years of operational, strategic, and clinical development experience in biotech and health technology. Most recently, Dr. Strong is the founder and CEO of Propagate Health, which builds problem-oriented innovation networks across healthcare, life sciences, and technology stakeholders.
Previously, Dr. Strong was President and Chief Operating Officer of Quintessence Biosciences, where she was responsible for developing and executing the company’s cancer drug development plans.
Laura is an adjunct faculty member in the Masters in Biotechnology program at the University of Wisconsin-Madison and serves on the boards of a variety of small private companies. She is a mentor in and co-chair of the screening committee for Madison Entrepreneurs Resource Learning and Innovation Network (MERLIN) mentors, which matches experienced and new entrepreneurs.
As a National Institutes of Health predoctoral fellow, Dr. Strong earned a Ph.D. in organic chemistry at the University of Wisconsin–Madison. Dr. Strong is co-author of 18 publications and co-inventor on 10 issued patents.
Social Media & Cancer Drugs: Conversation, not Promotion
[Updated 1/23/14, 2:23 pm.] Social media hasn’t yet changed the world for biotech and pharma companies, but I believe this year is the year that will change. For better or worse, these tools change the way people can communicate about specific things in business, politics, entertainment, and more. Online communities of cancer patients, physicians, and … Continue reading “Social Media & Cancer Drugs: Conversation, not Promotion”